Regenerative medicine scientists at IDIBELL in collaboration with partners at Ulm University (Germany) have demonstrated that inhibition of Cdc42 with CASIN can pharmacologically extend lifespan.
The Program for advancing the Clinical Translation of Regenerative Medicine of Catalonia (P-CMR[C]), which aims to group research on stem cells in Catalonia, now has its own space in internet.
The team of Dra. Anna Veiga, who leads the study, will optimize the CRISPR/Cas9 technique to modify the human embryo genome
Two researchers from IDIBELL and P-CMR[C], have been awarded in this edition of the City of Barcelona Awards, in the Life Sciences category
An international team led by researchers from Ulm and Barcelona has now discovered special niches in the bone marrow that protect haematopoietic stem cells from ageing processes
The new Clinical Translational Program for Regenerative Medicine in Catalonia (P-CMR [C]), propelled by the Center of Regenerative Medicine in Barcelona (CMR[B])…
